Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions

Details for Australian Patent Application No. 2011201337 (hide)

Owner Bayer Pharmaceuticals Corporation

Inventors Riedl, Bernd; Dumas, Jacques; Wilhelm, Scott; Boyer, Stephen

Agent Davies Collison Cave

Pub. Number AU-A-2011201337

Parent 2004259760

Filing date 23 March 2011

Wipo publication date 14 April 2011

International Classifications

C07D 213/78 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4415 (2006.01) - Pyridoxine, i.e.vitamin B

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61P 35/00 (2006.01) Antineoplastic agents

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

7 April 2011 Complete Application Filed

14 April 2011 Application Open to Public Inspection

  Published as AU-A-2011201337

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201338-Antimicrobial compositions and methods

2011201336-Modulo embedding of video parameters